Navigation Links
Atherosclerosis and its Mechanics

Atherosclerosis and the changes associated with it begin at vessel branches and this kind of mechanical stretching begins at those branches which activate// a cellular protein that has been known to damage cells The report is the first to link mechanical forces with structural and biochemical changes in blood vessel cells that could explain why atherosclerotic lesions form preferentially at branches of coronary arteries.

The findings, which are currently available online at the journal's Website, were reported by a team of scientists at the University of California, San Diego as part of an ongoing effort to understand how mechanical forces affect the health of cells that line arteries

The cellular protein in question is called JNK, which is short for c-jun N-terminal kinase. The protein is a key barometer of outside stresses on a variety of cell types. Researchers are examining the role of JNK in many diseases because it regulates the expression of genes involved in programmed cell death, tumor genesis, and other stress responses.

Atherosclerosis, the collection of deposits such as cholesterol along artery walls, accounts for nearly 75 percent of deaths from cardiovascular disease. Most drugs to treat atherosclerosis influence the levels of cholesterol and other lipids in the blood, but the UCSD researchers suspect that understanding the role of mechanical forces acting on blood vessel cells may help to design better approaches to treatment.

"We've known for decades that atherosclerotic lesions develop preferentially at vessel branches rather than along unbranched vessels, but we've not been able to identify the biochemical events that trigger formation of the lesions," said Shu Chien, director of the Whitaker Institute of Biomedical Engineering at UCSD. "We now have identified a possible smoking gun: activation of JNK, which is dependent on the directionality of blood vessel stretching."

Chien, res earch scientist Shunichi Usami, and post-doctoral fellow Roland Kaunas, now an assistant professor of biomedical engineering at Texas A&M University, isolated endothelial cells from the bovine aorta and grew them in culture flasks. They seeded the cells onto silicone rubber membranes that had been coated with a protein that allowed the cells to attach the way they do to underlying blood vessel tissue in the body. They then stretched the cells 10 percent of their length 60 times per minute to simulate the rhythmic flexing of an artery in response to heart beats.

Cells that were stretched back and forth along one axis exhibited a healthy response: the level of JNK rose and quickly returned to basal levels as the cells also produced intracellular actin fibers that were aligned perpendicular to the axis of stretching. However, when the researchers stretched cells in two directions simultaneously, they noted an unhealthy response: actin fibers oriented randomly and JNK concentrations rose to higher levels and remain elevated.

"We're continually amazed at how quickly these cells can reorient these stress fibers when we change the direction of stretch," said Chien. "At the same time, the actin cytoskeleton of endothelial cells is somehow playing a key role in activating and deactivating JNK."

The tubular geometry of the straight part of arteries ensures that the cyclical rise and fall of blood pressure results in uniaxial stretch of arteries. However, the more complex geometry of artery branches promotes an unhealthy stretching of the blood vessel along more than one axis.

A second mechanical force, the so-called shear force of blood flowing through vessels, also influences the orientation of stress fibers in endothelial cells. A laminar flow of blood prompts stress fibers to orient in the healthy direction, while disturbed and low blood flows caused stress fibers to form in an unhealthy, random orientation. Chien's group i s now working to understand how both stretching and shear forces influence JNK activation.

"We still need to limit the amount of cholesterol in our diet, especially the low-density lipoprotein, or bad cholesterol," said Chien. "But our new understanding of how mechanical forces affect JNK will eventually help us gain better understanding of the mechanism underlying the focal localization of atherosclerotic lesions and design better approaches to treat this important disease state."

(Eurekalert)
'"/>




Related medicine news :

1. Increase Cereal Fibre To Combat Atherosclerosis
2. Link Established Between Atherosclerosis and Air Pollution
3. Vegetarian Diet Prevents the Development of Atherosclerosis
4. Mothers Healthy Diet Protects Baby from Developing Atherosclerosis
5. Reducing the Risk of Protease Inhibitor-Related Atherosclerosis
6. Anti Atherosclerosis Therapies Linked to Leukemia
7. Early Onset of Atherosclerosis Reported in Obese Children
8. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... ... 2017 , ... Pink Pig Publishing LLC announces the launch ... the world from different perspectives. By providing a place for people of all ... empathy, and find greater happiness. , "Our approach to structuring content is ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for ... Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory ... disorder (ASD) to see films in an environment that accommodates their unique needs. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 Research and Markets has ... Strategies - 2016" report to their offering. ... The latest research Fibromyalgia Drugs ... benchmarks in the global Fibromyalgia market. The research answers ... drugs marketed for Fibromyalgia and their clinical attributes? How are they ...
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Analysis & Trends - Industry Forecast to 2025" report to ... ... of around 6.9% over the next decade to reach approximately $47.6 ... market estimates and forecasts for all the given segments on global ...
(Date:2/23/2017)... 2017  MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic, and Dental sectors of healthcare, today announced its ... ended December 31, 2016. Full Year 2016 ... 31% increase over full year 2015 revenue ...
Breaking Medicine Technology: